Discontinued — last reported Q4 '25
Quanta Services Acquisitions decreased by 98.2% to $22.94M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.2%, from $394.26M to $22.94M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 5.6% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $35.33M | $33.26M | $2.35B | $0.00 | $4.81M | $172.96M | $17.32M | $452.25M | $0.00 | $20.39M | $178.98M | $384.07M | $66.73M | $1.27B | $21.30M | $394.26M | $191.84M | $1.20B | $1.27B | $22.94M |
| QoQ Change | — | -5.9% | >999% | -100.0% | — | >999% | -90.0% | >999% | -100.0% | — | +777.7% | +114.6% | -82.6% | >999% | -98.3% | >999% | -51.3% | +524.0% | +6.0% | -98.2% |
| YoY Change | — | — | — | — | -86.4% | +420.0% | -99.3% | — | -100.0% | -88.2% | +933.3% | -15.1% | — | >999% | -88.1% | +2.7% | +187.5% | -6.0% | >999% | -94.2% |